Both in Pharmaceuticals
Moleculin Biotech vs Actuate Therapeutics
Over the past year MBRX returned −96.8% and ACTU returned −94.8%; their daily moves had a correlation of -0.05.
MBRX −96.8% ACTU −94.8%Growth of $1, one year, split-adjusted
| Metric | MBRX | ACTU |
|---|---|---|
| Price | $8.30 | $0.3500 |
| Market cap | $8.5M | $8.4M |
| Today | −0.24% | +2.34% |
| 1 month | −12.9% | −60.0% |
| 6 months | −83.3% | −88.6% |
| Year to date | −87.5% | −94.3% |
| 1 year | −96.4% | −94.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 850.7% | 161.0% |
| Short % of float | 0.7% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).